FDA News
Most Popular FDA Story
REMS sans registry may get one
In backing the approval of InterMune's pirfenidone for idiopathic pulmonary fibrosis, an FDA panel voted that the drug's safety had been adequately assessed, despite some concerns. Panelists urged... Read more...
Latest Headlines
- March 10, 2010
- February 15, 2010
- February 3, 2010
- February 3, 2010
- February 1, 2010
- January 12, 2010
- December 2, 2009
- December 1, 2009
- December 1, 2009
- December 1, 2009
- November 12, 2009
- November 10, 2009
- August 4, 2009
- July 22, 2009
- June 15, 2009
- June 10, 2009
- May 26, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
